C133H173Cl3F5N11O8 — CID 158362090
(2R)-2-[(3S,4S)-3-[[4-[3-(2-chloro-4-fluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-cyclobutylpropanoic acid;(2R)-2-[(3S,4S)-3-[[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]propyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,5-dichlorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-(3-imidazo[1,2-a]pyridin-6-ylpropyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid (PubChem CID 158362090) has the molecular formula C133H173Cl3F5N11O8 and a molecular weight of 2255.26 g/mol. Its IUPAC name is (2R)-2-[(3S,4S)-3-[[4-[3-(2-chloro-4-fluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-cyclobutylpropanoic acid;(2R)-2-[(3S,4S)-3-[[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]propyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,5-dichlorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-(3-imidazo[1,2-a]pyridin-6-ylpropyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid.
| Compound Name | (2R)-2-[(3S,4S)-3-[[4-[3-(2-chloro-4-fluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-cyclobutylpropanoic acid;(2R)-2-[(3S,4S)-3-[[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]propyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,5-dichlorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-(3-imidazo[1,2-a]pyridin-6-ylpropyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid |
|---|---|
| PubChem CID | 158362090 |
| Molecular Formula | C133H173Cl3F5N11O8 |
| Molecular Weight | 2255.26 g/mol |
| Exact Mass | 2252.25 |
| IUPAC Name | (2R)-2-[(3S,4S)-3-[[4-[3-(2-chloro-4-fluorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-cyclobutylpropanoic acid;(2R)-2-[(3S,4S)-3-[[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]propyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-3-cyclobutyl-2-[(3S,4S)-3-[[4-[3-(3,5-dichlorophenyl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-(3-imidazo[1,2-a]pyridin-6-ylpropyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid |
| SMILES | N#Cc1ccc(CCCC2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3cccc(F)c3)CC2)cc1C(F)(F)F.O=C(O)C(CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3Cl)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccc4nccn4c3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3cc(Cl)cc(Cl)c3)CC2)[C@@H](c2ccccc2)C1 |
| InChI | InChI=1S/C35H43F4N3O2.C34H46N4O2.C32H42Cl2N2O2.C32H42ClFN2O2/c36-30-11-5-10-27(19-30)31-23-42(33(34(43)44)26-8-2-1-3-9-26)22-29(31)21-41-16-14-24(15-17-41)6-4-7-25-12-13-28(20-40)32(18-25)35(37,38)39;39-34(40)33(29-12-5-2-6-13-29)38-24-30(31(25-38)28-10-3-1-4-11-28)23-36-19-16-26(17-20-36)8-7-9-27-14-15-32-35-18-21-37(32)22-27;33-28-16-25(17-29(34)19-28)9-4-6-23-12-14-35(15-13-23)20-27-21-36(22-30(27)26-10-2-1-3-11-26)31(32(37)38)18-24-7-5-8-24;33-30-19-28(34)13-12-26(30)11-5-6-23-14-16-35(17-15-23)20-27-21-36(22-29(27)25-9-2-1-3-10-25)31(32(37)38)18-24-7-4-8-24/h5,10-13,18-19,24,26,29,31,33H,1-4,6-9,14-17,21-23H2,(H,43,44);1,3-4,10-11,14-15,18,21-22,26,29-31,33H,2,5-9,12-13,16-17,19-20,23-25H2,(H,39,40);1-3,10-11,16-17,19,23-24,27,30-31H,4-9,12-15,18,20-22H2,(H,37,38);1-3,9-10,12-13,19,23-24,27,29,31H,4-8,11,14-18,20-22H2,(H,37,38)/t29-,31+,33+;30-,31+,33+;27-,30+,31+;27-,29+,31?/m0000/s1 |
| InChIKey | GTPCWFZSUPXWFU-ONSQTDOOSA-N |
| XLogP | 27.88 |
| TPSA | 216.21 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 42 |
| Heavy Atoms | 160 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2255.26 |
| LogP ≤ 5 | 27.88 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 15 |